- Home
- AMRX vs GENI Comparison
AMRX vs GENI Comparison
Compare AMRX & GENI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- GENI
- Stock Information
- Founded
- AMRX 2002
- GENI 2016
- Country
- AMRX United States
- GENI United Kingdom
- Employees
- AMRX N/A
- GENI N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- GENI Services-Misc. Amusement & Recreation
- Sector
- AMRX Health Care
- GENI Consumer Discretionary
- Exchange
- AMRX Nasdaq
- GENI Nasdaq
- Market Cap
- AMRX 2.4B
- GENI 2.1B
- IPO Year
- AMRX N/A
- GENI N/A
- Fundamental
- Price
- AMRX $7.36
- GENI $10.33
- Analyst Decision
- AMRX Strong Buy
- GENI Strong Buy
- Analyst Count
- AMRX 5
- GENI 12
- Target Price
- AMRX $10.80
- GENI $11.79
- AVG Volume (30 Days)
- AMRX 2.0M
- GENI 3.7M
- Earning Date
- AMRX 05-02-2025
- GENI 05-07-2025
- Dividend Yield
- AMRX N/A
- GENI N/A
- EPS Growth
- AMRX N/A
- GENI N/A
- EPS
- AMRX N/A
- GENI N/A
- Revenue
- AMRX $2,793,957,000.00
- GENI $510,894,000.00
- Revenue This Year
- AMRX $10.49
- GENI $23.33
- Revenue Next Year
- AMRX $7.00
- GENI $16.38
- P/E Ratio
- AMRX N/A
- GENI N/A
- Revenue Growth
- AMRX 16.73
- GENI 23.71
- 52 Week Low
- AMRX $5.18
- GENI $4.91
- 52 Week High
- AMRX $9.48
- GENI $11.16
- Technical
- Relative Strength Index (RSI)
- AMRX 40.90
- GENI 57.82
- Support Level
- AMRX $6.69
- GENI $9.12
- Resistance Level
- AMRX $7.29
- GENI $9.85
- Average True Range (ATR)
- AMRX 0.39
- GENI 0.63
- MACD
- AMRX -0.04
- GENI 0.05
- Stochastic Oscillator
- AMRX 35.71
- GENI 95.82
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.